The Breast · 2012 · 39 citations · 41 references
MedicineCancer BiologyOncologyBreast OncologyMetastasisMolecular OncologyMammary TumorsMetastatic Breast CancerMolecular Tumor ProfilingLymph Node Metastasis BiomarkersLymph Node Metastasis PrognosisMatrix Metalloproteinase Gene ExpressionMatrix Metalloproteinase InhibitorsMatrix Metalloproteinase ProcessingMatrix Metalloproteinases
BACKGROUND: We examined mRNA expression for MMP-2, MMP-7, MMP-9, MT1-MMP, TIMP-1, and TIMP-2 in human breast cancer tissues, and the association between their expression and clinicopathological variables. PATIENTS AND METHODS: Breast tissue samples from 120 patients with breast cancer were available for this study. To determine mRNA expression for MMP-2, MMP-7, MMP-9, MT1-MMP, TIMP-1, and TIMP-2, semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was carried out on tumor and normal tissues, respectively. RESULTS: Mean MMP-2, MMP-7, MMP-9, MT1-MMP, TIMP-1, and TIMP-2 mRNA expression in the breast cancer was significantly higher than in the normal tissue. In terms of tumor size and lymph node metastasis of breast cancer, the differences in MMP-2, MMP-7, MMP-9, and MT1-MMP mRNA expression levels were significant. CONCLUSION: The association between the increased expression of MMP-2, MMP-7, MMP-9, and MTI-MMP and clinicopathological parameters reflects a role in predicting the aggressive behavior of breast cancer.
41
James R. Egner · JAMA · 2010 · 6.1K citations
Antisense RNA-Induced Reduction in Murine TIMP Levels Confers Oncogenicity on Swiss 3T3 Cells
Rama Khokha, Paul Waterhouse, Simcha Yagel et al. · Science · 1989 · 457 citations
Medicine, Cancer Biology, Oncology +10